Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma.
Dweik RA, Sorkness RL, Wenzel S, Hammel J, Curran-Everett D, Comhair SA, Bleecker E, Busse W, Calhoun WJ, Castro M, Chung KF, Israel E, Jarjour N, Moore W, Peters S, Teague G, Gaston B, Erzurum SC; National Heart, Lung, and Blood Institute Severe Asthma Research Program.
Dweik RA, et al. Among authors: sorkness rl.
Am J Respir Crit Care Med. 2010 May 15;181(10):1033-41. doi: 10.1164/rccm.200905-0695OC. Epub 2010 Feb 4.
Am J Respir Crit Care Med. 2010.
PMID: 20133930
Free PMC article.